drugset / Trial / NCT05372003
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils, their secreted cytokines (interleukin-4), and metabolism in human health and disease states such as obesity and insulin resistance.
Timeline
- Start
- 2022-08-09
- Primary completion
- 2024-02-23
- Completion
- 2024-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dupilumab | Monoclonal antibody | — | — |